|
Volumn 58, Issue 7, 1996, Pages 573-583
|
Chronic anabolic-androgenic steroid treatment affects brain GABAA receptor-gated chloride ion transport
|
Author keywords
3 androstanediol; Abuse; Androsterone; Dianabol; Neurosteroids; Tolerance; Withdrawal
|
Indexed keywords
3BETA ANDROSTANEDIOL;
4 AMINOBUTYRIC ACID;
4 AMINOBUTYRIC ACID A RECEPTOR;
5ALPHA ANDROSTAN 17ALPHA METHYL 3ALPHA,17BETA DIOL;
5ALPHA ANDROSTAN 17ALPHA METHYL 3BETA, 17BETA DIOL;
ANABOLIC AGENT;
ANDROSTANEDIOL;
ANDROSTERONE;
CHLORINE 36;
DRUG METABOLITE;
METANDIENONE;
NEUROSTEROID;
UNCLASSIFIED DRUG;
ANDROGEN METABOLISM;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BRAIN CORTEX;
BRAIN SYNAPTOSOME;
CHLORIDE TRANSPORT;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG WITHDRAWAL;
HORMONE BLOOD LEVEL;
MALE;
NONHUMAN;
ORGAN WEIGHT;
PROSTATE VENTRAL LOBE;
RAT;
SUBCUTANEOUS DRUG ADMINISTRATION;
TESTIS WEIGHT;
TRANQUILIZING ACTIVITY;
ANABOLIC AGENTS;
ANIMALS;
BINDING SITES;
BRAIN;
CHLORIDE CHANNELS;
GAMMA-AMINOBUTYRIC ACID;
HYPOTHALAMUS;
ION TRANSPORT;
MALE;
METHANDROSTENOLONE;
ORGAN SIZE;
RATS;
RECEPTORS, GABA-A;
TESTIS;
|
EID: 0030069886
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/0024-3205(95)02326-7 Document Type: Article |
Times cited : (50)
|
References (39)
|